Study for people with Atypical Haemolytic Uraemic Syndrome

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Alexion Pharmaceuticals, Inc.
Registry number NCT01522183
Started 18 March 2013 Today 16 October 2026 Estimated completion 1 January 2031

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Clinical Trial Site 1 Westmead NSW Recruiting
Clinical Trial Site 2 Westmead NSW Recruiting
Clinical Trial Site Cairns QLD Recruiting
Clinical Trial Site Herston QLD Recruiting
Clinical Trial Site Woolloongabba QLD Recruiting
Clinical Trial Site Adelaide SA Recruiting
Clinical Trial Site Heidelberg VIC Recruiting
Clinical Trial Site Parkville VIC Recruiting
Clinical Trial Site Parkville VIC Recruiting
Clinical Trial Site Murdoch WA Recruiting
Clinical Trial Site Nedlands WA Active not recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age child, adult, older adult
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 3000

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Male or female patients of any age, including minors, who have been diagnosed with aHUS

* Patients with or without an identified complement pathogenic variant or anti-complement factor antibody

* Able to give written informed consent. Patient or patient's parent/legal guardian must be willing and able to given written informed consent and the patient (if minor) must be willing to give written informed assent \[if applicable as determined by the central Institutional Review Boards/Independent Ethics Committees (IRB/IEC)\].

* ADAMTS13 \> 5%, if performed.

Exclusion Criteria:

* Hemolytic Uremic Syndrome (HUS) only due to Shiga Toxin producing Escherichia coli (STEC).

* Unable to give written informed consent. Patient or patient's parent/legal guardian unable to give written informed consent. Patient (if minor) unable to give written informed assent (if applicable as determined by the central Institutional Review Boards/Independent Ethics Committees \[IRB/IEC\]).

Dates on the record

Started 18 March 2013
Estimated completion 1 January 2031
Registry last updated 16 September 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 16 September 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.